Agendia Co-Founder Named to Eighth Annual OncLive® Giants of Cancer Care® Class of Inductees
Laura van ’t Veer among 15 trailblazers in oncology honored Read More
MammaPrint® Approved for Reimbursement in Germany
IRVINE, Calif., Oct. 21, 2020 /PRNewswire/ -- Agendia Inc., a world leader in Read More
Agendia to Participate in Stifel 2020 Virtual Healthcare Conference
Irvine, Calif., October 15, 2020 – Agendia, Inc., a world Read More
Agendia, HiSS Diagnostics and PathoNext offer local MammaPrint and BluePrint testing for breast cancer patients in Germany
IRVINE, CALIF., U.S – 6 October 2020 – Agendia Inc., Read More
Agendia Celebrates Breast Cancer Awareness Month with Digital Art Installation
I AM HERE: An Intimate Portrait Series launches today Irvine, Read More
Agendia Presents New Data Demonstrating MammaPrint’s Clinical Utility in Treatment Decisions for Ultra-Low Risk Breast Cancer Patients at the European Society for Medical Oncology Virtual Congress
Irvine, California – September 17, 2020 – Agendia, Inc., a Read More
Agendia to Showcase New Data at the European Society for Medical Oncology Virtual Congress 2020
IRVINE, Calif., Sept. 14, 2020 /CNW/ - Agendia, Inc. a world leader in Read More
MINDACT Study Shows MammaPrint® Provides Widespread Health System Cost Savings
Analysis Published in European Journal of Cancer Use of MammaPrint Read More
Agendia Included on the 2020 Inc. 5000 List With Three-Year Revenue Growth Approaching 90%
Inc. Magazine Unveils Its Annual List of America’s Fastest-Growing Private Read More
Agendia Expands Management Team to Meet Company Momentum, Appoints Brian Dow as Chief Financial Officer
Chief Operating Officer Kurt Becker to Take on Broadened Role Read More